MIRA Total Stockholder Equity vs Total Assets Analysis
| MIRA Stock | 1.32 0.06 4.76% |
MIRA Pharmaceuticals, financial indicator trend analysis is infinitely more than just investigating MIRA Pharmaceuticals, recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether MIRA Pharmaceuticals, is a good investment. Please check the relationship between MIRA Pharmaceuticals, Total Stockholder Equity and its Total Assets accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MIRA Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Total Stockholder Equity vs Total Assets
Total Stockholder Equity vs Total Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of MIRA Pharmaceuticals, Total Stockholder Equity account and Total Assets. At this time, the significance of the direction appears to have almost identical trend.
The correlation between MIRA Pharmaceuticals,'s Total Stockholder Equity and Total Assets is 0.9. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Total Assets in the same time period over historical financial statements of MIRA Pharmaceuticals, Common, assuming nothing else is changed. The correlation between historical values of MIRA Pharmaceuticals,'s Total Stockholder Equity and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of MIRA Pharmaceuticals, Common are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Total Stockholder Equity i.e., MIRA Pharmaceuticals,'s Total Stockholder Equity and Total Assets go up and down completely randomly.
Correlation Coefficient | 0.9 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Total Assets
Total assets refers to the total amount of MIRA Pharmaceuticals, assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in MIRA Pharmaceuticals, books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Most indicators from MIRA Pharmaceuticals,'s fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into MIRA Pharmaceuticals, current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MIRA Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. The current year's Selling General Administrative is expected to grow to about 6.8 M, whereas Issuance Of Capital Stock is forecasted to decline to about 6.1 M.
| 2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 24.4K | 10.3K | 3.5M | 3.6M | Depreciation And Amortization | 2.2K | 7.0K | 8.5M | 9.0M |
MIRA Pharmaceuticals, fundamental ratios Correlations
Click cells to compare fundamentals
MIRA Pharmaceuticals, Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MIRA Pharmaceuticals, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MIRA Pharmaceuticals,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mira Pharmaceuticals, Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mira Pharmaceuticals, Common Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MIRA Pharmaceuticals, Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MIRA Pharmaceuticals,. If investors know MIRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MIRA Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.55) | Return On Assets (1.78) | Return On Equity (7.49) |
The market value of MIRA Pharmaceuticals, is measured differently than its book value, which is the value of MIRA that is recorded on the company's balance sheet. Investors also form their own opinion of MIRA Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is MIRA Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MIRA Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect MIRA Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MIRA Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if MIRA Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MIRA Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.